Screener
Mesa Laboratories MLAB Calibration Solutions — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Three months ended June 30, 2026 | Sterilization and Disinfection Control | Biopharmaceutical Development | Calibration Solutions | Clinical Genomics | Total |
|---|---|---|---|---|---|
| Amortization in cost of revenue | 121 | 379 | - | 191 | 691 |
| Other cost of revenue (b) | 6,788 | 4,020 | 5,143 | 3,739 | 19,690 |
| Total segment cost of revenue | 7,346 | 4,477 | 5,254 | 4,049 | 21,126 |
| Gross Profit (c) | $17,159 | $7,582 | $8,031 | $6,240 | $39,012 |
| Reconciling items: | |||||
| Operating expense | $31,981 | ||||
| Operating income | 7,031 | ||||
| Non-operating expense, net | 2,678 |
Document
FAQ
- What is Mesa Laboratories's calibration solutions — gross profit?
- Mesa Laboratories (MLAB) reported calibration solutions — gross profit of $8.03M in Q2 2026.
- How has Mesa Laboratories's calibration solutions — gross profit changed year-over-year?
- Mesa Laboratories's calibration solutions — gross profit increased by 14.0% year-over-year, from $7.04M to $8.03M.
- What does calibration solutions — gross profit mean?
- This represents the residual profit of the Calibration Solutions segment after deducting the cost of revenue from total segment net revenue. It is a critical measure of the segment's pricing power and the efficiency of its manufacturing or service delivery processes.
Ask your AI about Mesa Laboratories's calibration solutions — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude